Anti-PD-1 tolerance after severe toxicity with ipilimumab therapy in metastatic melanoma patients

Authors :: Yannick Le Corre
Henri Montaudié
Bernard Guillot
Thierry Lesimple
Céleste Lebbé
Sorilla Prey
Boris Campillo-Gimenez
Astrid Blom
Nora Kramkimel
Angélique Brunot
Sandrine Mansard
Laurent Mortier
Géraldine Jeudy
Mathieu Tas
Source :: Journal of Clinical Oncology. 34:9551-9551
Publication Year :: 2016
Publisher :: American Society of Clinical Oncology (ASCO), 2016.
Abstract: 9551Background: Anti-Cytotoxic T-Lymphocyte Antigen-4 (CTLA-4) antibody ipilimumab has been proved efficacy in treatment of metastatic melanoma, but with immune-related adverse events (irAE). Anti-...

Full Text Access

Tools